Trial site
Tel Aviv Sourasky Medical Center PPDS
Tel Aviv, 64239, IsraelNot linked to an institution yet
- 5running trials
- 8closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 12 trials
- Phase 1/21 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Genentech, Inc.2 trials
- Takeda2 trials
- United Therapeutics2 trials
- Agios Pharmaceuticals, Inc.1 trial
- Hoffmann-La Roche1 trial
- and 5 more
Running trials
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
NCT05927571· Phase 1· Genentech, Inc.· Source
Active, not recruiting
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
NCT05646836· Phase 1· Genentech, Inc.· Source
Active, not recruiting
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
NCT05490446· Phase 2· Agios Pharmaceuticals, Inc.· Source
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693· Phase 3· United Therapeutics· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Withdrawn
A Study to Investigate Leramistat in Patients With IPF
NCT05951296· Phase 2· Modern Biosciences Ltd· Source
Completed
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480· Phase 2· Shionogi· Source
Completed
Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT05255991· Phase 3· United Therapeutics· Source
Completed
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
NCT05199337· Phase 1/2· K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.· Source
Terminated
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
NCT05085366· Phase 3· ModernaTX, Inc.· Source
Terminated
A Study of Soticlestat in Adults and Children With Rare Epilepsies
NCT03635073· Phase 2· Takeda· Source
Completed
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
NCT03283085· Phase 3· Shire· Source
Completed
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
NCT03268954· Phase 3· Takeda· Source
Report an error